Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4; this is minor metadata with no visible changes to the study’s content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now includes a Barcelona location under the Locations section and the revision is updated to v3.3.3, while the prior Barcelona Locations entry and the HHS Vulnerability Disclosure link have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T10:18:05.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 after the prior v3.2.0, an internal version update that does not affect user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:48:10.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, an administrative banner that does not affect the study details or data presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:38:45.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    No meaningful changes detected in the Study Details page for NCT03276013 (Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer).
    Difference
    0.5%
    Check dated 2025-11-03T12:27:34.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Major update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:19:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.